English | 简体中文 | 繁體中文 | 한국어 | 日本語
  Press Releases
Wednesday, December 20, 2023
欧康维视生物: OT-703获批于香港上市,为糖尿病性黄斑水肿患者治疗带来新选择
歐康維視生物: OT-703獲批於香港上市,為糖尿病性黃斑水腫患者治療帶來新選擇
Ocumension Therapeutics: The Approval Received For Marketing OT-703 In Hong Kong, A New Option For Patients With Diabetic Macular Edema
Thursday, August 24, 2023
欧康维视公布2023年中期业绩
歐康維視公佈2023年中期業績
Ocumension Therapeutics Announces 2023 Interim Results
Thursday, March 30, 2023
欧康维视公布2022年全年业绩
歐康維視公佈2022年全年業績
Ocumension Therapeutics Announces 2022 Annual Results
Monday, March 13, 2023
欧康维视获纳入沪港通及深港通名单

Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575